Drug recall · February 1, 2023
0.9% Sodium Chloride Injection recall
Why: CGMP Deviations: potential for trace amounts of product carryover.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.
- Lots / codes
Lot: 271043, Exp. 03/2023
- Quantity
- 378 bags
- Company
- Nephron Sc Inc, West Columbia, SC
- Distribution
- Nationwide in the USA
- Initiated
- January 12, 2023 · Voluntary: Firm initiated
- Classified
- January 24, 2023
- Reported
- February 1, 2023
- Ended
- October 11, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium chloride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.